Asthma information
September 16, 2010
THE National Asthma Council
Australia has updated its
information paper titled:
Leukotriene receptor antagonists in
the management of childhood
asthma to reflect the latest clinical
evidence, drug therapies and
physiological data.
Last updated in 2007, the paper
discusses the role of Leukotriene
receptor antagonists (LTRAs),
including montelukast, in the
treatment of children aged between
two and 14 years suffering from
mild persistent asthma, intermittent
asthma, exercise-induced asthma
and/or allergic rhinitis.
The updated paper will be
distributed to GPs and pharmacists
over the next few months, and is
also available online at
www.nationalasthma.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 10